CHANGE: AstraZeneca, Oxford resume COVID-19 vaccine trials after one fell ill. “AstraZeneca, which has been working with the University of Oxford as the trial sponsor, announced a pause in the global trials after one of its volunteers fell ill with an unexplained illness Sunday. . . . The volunteer experienced neurological symptoms linked to a rare spinal inflammatory disorder transverse myelitis.”